Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats.

Ettenberg A, Cotten SW, Brito MA, Klein AK, Ohana TA, Margolin B, Wei A, Wenzel JM.

Pharmacol Biochem Behav. 2015 Nov;138:148-55. doi: 10.1016/j.pbb.2015.10.002. Epub 2015 Oct 8.

PMID:
26441142
2.

Dopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administration.

Yan Y, Newman AH, Xu M.

Neuroscience. 2014 Oct 10;278:154-64. doi: 10.1016/j.neuroscience.2014.08.008. Epub 2014 Aug 20.

3.

Diminished role for dopamine D1 receptors in cocaine addiction?

Self DW.

Biol Psychiatry. 2014 Jul 1;76(1):2-3. doi: 10.1016/j.biopsych.2014.04.006. No abstract available.

4.

Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse.

Cahill E, Salery M, Vanhoutte P, Caboche J.

Front Pharmacol. 2014 Jan 8;4:172. doi: 10.3389/fphar.2013.00172. Review.

5.

The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Wenzel JM, Su ZI, Shelton K, Dominguez HM, von Furstenberg VA, Ettenberg A.

Pharmacol Biochem Behav. 2013 Dec;114-115:90-6. doi: 10.1016/j.pbb.2013.08.014. Epub 2013 Sep 5.

6.

Rational development of addiction pharmacotherapies: successes, failures, and prospects.

Pierce RC, O'Brien CP, Kenny PJ, Vanderschuren LJ.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a012880. doi: 10.1101/cshperspect.a012880. Review.

7.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

8.

The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.

Liggins J, Pihl RO, Benkelfat C, Leyton M.

PLoS One. 2012;7(1):e28370. doi: 10.1371/journal.pone.0028370. Epub 2012 Jan 4.

9.

Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys.

Czoty PW, Gould RW, Martelle JL, Nader MA.

Neuropsychopharmacology. 2011 Jan;36(2):539-47. doi: 10.1038/npp.2010.185. Epub 2010 Oct 20.

10.

Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior.

Thiel KJ, Wenzel JM, Pentkowski NS, Hobbs RJ, Alleweireldt AT, Neisewander JL.

Behav Brain Res. 2010 Dec 25;214(2):386-94. doi: 10.1016/j.bbr.2010.06.021. Epub 2010 Jun 19.

11.

Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse.

Feltenstein MW, Do PH, See RE.

Psychopharmacology (Berl). 2009 Dec;207(3):401-11. doi: 10.1007/s00213-009-1671-8. Epub 2009 Sep 25.

12.

Anti-relapse medications: preclinical models for drug addiction treatment.

Yahyavi-Firouz-Abadi N, See RE.

Pharmacol Ther. 2009 Nov;124(2):235-47. doi: 10.1016/j.pharmthera.2009.06.014. Epub 2009 Aug 13. Review.

13.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

14.

c-Fos is an intracellular regulator of cocaine-induced long-term changes.

Xu M.

Ann N Y Acad Sci. 2008 Oct;1139:1-9. doi: 10.1196/annals.1432.049.

15.

Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC.

Neuropsychopharmacology. 2009 Apr;34(5):1277-87. doi: 10.1038/npp.2008.194. Epub 2008 Oct 22.

16.

Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Haney M.

Addict Biol. 2009 Jan;14(1):9-21. doi: 10.1111/j.1369-1600.2008.00121.x. Epub 2008 Oct 9. Review.

17.

Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats.

Thomsen M, Fink-Jensen A, Woldbye DP, W├Ârtwein G, Sager TN, Holm R, Pepe LM, Caine SB.

Psychopharmacology (Berl). 2008 Nov;201(1):43-53. doi: 10.1007/s00213-008-1245-1. Epub 2008 Jul 9.

18.

Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization.

Karlsson RM, Hefner KR, Sibley DR, Holmes A.

Psychopharmacology (Berl). 2008 Sep;200(1):117-27. doi: 10.1007/s00213-008-1165-0. Epub 2008 Jul 4.

19.

Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C, Tapper AR, Akbarian S.

Neuropsychopharmacology. 2008 Nov;33(12):2981-92. doi: 10.1038/npp.2008.15. Epub 2008 Feb 20.

20.

Controversies in translational research: drug self-administration.

Haney M, Spealman R.

Psychopharmacology (Berl). 2008 Aug;199(3):403-19. doi: 10.1007/s00213-008-1079-x. Epub 2008 Feb 19. Review.

Items per page

Supplemental Content

Write to the Help Desk